EcoDrugPlus

Amine Oxidase Copper Containing 1

Ensembl ID : ENSTNIG00000008780
Gene Symbol: AOC1
2 Cross references
230 Possible Orthologues:

Amine Oxidase Copper Containing 2

Ensembl ID : ENSTNIG00000004813
Gene Symbol: AOC2
2 Cross references
404 Possible Orthologues:

Amyloid Beta (A4) Precursor Protein B

Ensembl ID : ENSTNIG00000013912
Gene Symbol: APPB
2 Cross references
205 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSTNIG00000014537
Gene Symbol: APP
3 Cross references
203 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSTNIG00000011826
Gene Symbol: AR
2 Cross references
213 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSTNIG00000012757
Gene Symbol: AGTR1
2 Cross references
198 Possible Orthologues:

Angiotensin Ii Receptor, Type 2

Ensembl ID : ENSTNIG00000015777
Gene Symbol: AGTR2
2 Cross references
185 Possible Orthologues:

Apelin Receptor 2

Ensembl ID : ENSTNIG00000015968
Gene Symbol: APLNR2
2 Cross references
171 Possible Orthologues:

Arachidonate 5-Lipoxygenase A

Ensembl ID : ENSTNIG00000008673
Gene Symbol: ALOX5A
2 Cross references
225 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Activating Protein

Ensembl ID : ENSTNIG00000009910
Gene Symbol: ALOX5AP
2 Cross references
200 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSTNIG00000018724
Gene Symbol: AVPR1A
3 Cross references
195 Possible Orthologues:

Arginine Vasopressin Receptor 1ab

Ensembl ID : ENSTNIG00000006727
Gene Symbol: AVPR1AB
3 Cross references
170 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).